SAB Biotherapeutics, Inc. (SABS) Insider Ownership

Historic Ownership Trends

Through the 90-day period concluding December 12, 2025, SAB Biotherapeutics's top three insider stakeholders include Director Capital (Master), L.P. Sessa (2.20Mn shares), Director Andrew Moin (2.20Mn shares), Chief Medical Officer Alexandra Kropotova (45.27K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares Report Date
Christine E Hamilton 810,442 14 Sep, 2022
Eddie Joe Sullivan Chief Executive Officer 523,230 08 Dec, 2023
Edward D. Hamilton 505,444 26 Oct, 2021
Ilan Katz 304,933 15 Oct, 2021
Cypress Holdings Llc Big CEO And Cfo 304,783 14 Jan, 2021
Helen K. Ellias 285,714 28 Nov, 2023
Capital (Master), L.P. Sessa 2,198,457 01 Oct, 2025
Andrew Moin 2,198,457 01 Oct, 2025
Samuel J Reich Executive Chairman 76,670 30 Nov, 2023
Jeffrey G Spragens 39,499 09 Dec, 2022
David Charles Link 6,941 09 Dec, 2022
Alexandra Kropotova Chief Medical Officer 44,284 12 Dec, 2025
Frederick Finnegan Chief Business Officer 3,860 26 Oct, 2021
Thomas Charles Luke Chief Medical Officer 543 26 Oct, 2021
Michael King Chief Financial Officer 500 30 Nov, 2023
Russell P Beyer Chief Financial Officer 249 16 Nov, 2021

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
11 Dec, 2025 Alexandra Kropotova Common Stock D 988 - 44,284 D F
29 Sep, 2025 Andrew Moin Common Stock A 1,740,000 $1.75 2,198,457 I M
29 Sep, 2025 Andrew Moin - - 2,198,457 I
29 Sep, 2025 Capital (Master), L.P. Sessa Common Stock A 1,740,000 $1.75 2,198,457 D M
19 Sep, 2025 Alexandra Kropotova Common Stock D 1,977 - 45,272 D F
27 Mar, 2025 Alexandra Kropotova Common Stock D 1,179 - 47,249 D F
18 Dec, 2024 Alexandra Kropotova Common Stock D 9,072 - 48,428 D F
07 Dec, 2023 Eddie Joe Sullivan - - 523,230 D
07 Dec, 2023 Eddie Joe Sullivan Common Stock A 1,740 $0.88 523,230 D P
30 Nov, 2023 Michael King Common Stock A 5,000 $0.90 500 D P
30 Nov, 2023 Michael King - - 500 D
29 Nov, 2023 Samuel J Reich - - 21,900 D
29 Nov, 2023 Samuel J Reich Common Stock A 11,000 $0.89 21,900 D P
24 Nov, 2023 Andrew Moin Common Stock A 4,584,571 - 458,457 I M
24 Nov, 2023 Helen K. Ellias - - 285,714 I
24 Nov, 2023 Capital (Master), L.P. Sessa Common Stock A 4,584,571 - 458,457 D M
24 Nov, 2023 Helen K. Ellias Common Stock A 2,857,142 - 285,714 I M
14 Mar, 2023 Alexandra Kropotova Common Stock A 275,000 - 27,500 D A
14 Mar, 2023 Alexandra Kropotova - - 27,500 D
07 Dec, 2022 Christine E Hamilton Common Stock A 82,987 $1.20 311,133 I A